42 assets in Abdominal Obesity-Metabolic Syndrome

Therapeutic assets addressing Abdominal Obesity-Metabolic Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Topiramate Abdominal Obesity-Metabolic Syndrome	All India Institute of Medical Sciences, Bhubaneswar	P4	BBB (74)
Rosuvastatin Abdominal Obesity-Metabolic Syndrome	Hamdard University	P4	BBB (72)
Ezetimibe Abdominal Obesity-Metabolic Syndrome	Samsung Medical Center	P4	BB (71)
Telmisartan Abdominal Obesity-Metabolic Syndrome	Hamdard University	P4	BB (70)
Hydrochlorothiazide Abdominal Obesity-Metabolic Syndrome	UMC Utrecht	P4	BB (69)
Testosterone Undecylate Abdominal Obesity-Metabolic Syndrome	Royal College of Surgeons, Ireland	P4	BB (69)
Umbellatine Abdominal Obesity-Metabolic Syndrome	Nanjing First Hospital, Nanjing Medical University	P4	BB (69)
Empagliflozin Abdominal Obesity-Metabolic Syndrome	Abdelrahman Mahmoud	P4	BB (68)
Liraglutide Abdominal Obesity-Metabolic Syndrome	University of Virginia	P4	BB (68)
Semaglutide Abdominal Obesity-Metabolic Syndrome	Hallym University	P4	BB (68)
Bictegravir Abdominal Obesity-Metabolic Syndrome	Instituto Mexicano del Seguro Social	P4	B (63)
Tadalafil Abdominal Obesity-Metabolic Syndrome	Kafrelsheikh University	P4	B (63)
Lamivudine Abdominal Obesity-Metabolic Syndrome	Instituto Mexicano del Seguro Social	P4	B (62)
Sitagliptin Abdominal Obesity-Metabolic Syndrome	Hamdard University	P4	B (62)
Tenofovir Alafenamide Abdominal Obesity-Metabolic Syndrome	Instituto Mexicano del Seguro Social	P4	B (61)
(±)-Ftc Abdominal Obesity-Metabolic Syndrome	Instituto Mexicano del Seguro Social	P4	B (60)
Losartan Abdominal Obesity-Metabolic Syndrome	Chong Kun Dang Pharmaceutical	P4	B (60)
Bifidobacterium Tetravaccae Abdominal Obesity-Metabolic Syndrome	Nanjing First Hospital, Nanjing Medical University	P4	B (59)
Dolutegravir Abdominal Obesity-Metabolic Syndrome	Instituto Mexicano del Seguro Social	P4	B (59)
Envarsus Product Abdominal Obesity-Metabolic Syndrome	University of Alberta	P4	B (59)
Saroglitazar Abdominal Obesity-Metabolic Syndrome	Zydus Lifesciences Limited	P4	B (59)
Inv-202 Abdominal Obesity-Metabolic Syndrome	Inversago Pharma Inc.	P2	B (58)
Human Faecal Matter Abdominal Obesity-Metabolic Syndrome	Wiebke Kristin Fenske	P2	B (57)
Doravirine Abdominal Obesity-Metabolic Syndrome	Prism Health North Texas	P3	CCC (54)
Tongmai Jiangtang Abdominal Obesity-Metabolic Syndrome	Guangdong Provincial Hospital of Traditional Chinese Medicine	P3	CCC (54)
Vericiguat Abdominal Obesity-Metabolic Syndrome	Johns Hopkins University	P2	CCC (54)
Galantamine Hydrobromide Abdominal Obesity-Metabolic Syndrome	Northwell Health	P2/3	CCC (52)
Tenofovir Disoproxil Fumarate Abdominal Obesity-Metabolic Syndrome	Prism Health North Texas	P3	CCC (52)
Ae-Celery Seed Abdominal Obesity-Metabolic Syndrome	University of Guadalajara	P2	CCC (51)
Bifidobacterium Animalis Subsp. Lactis Bb-12 Abdominal Obesity-Metabolic Syndrome	Penn State University	P1/2	CC (43)
Cannabivarol, .Delta.9-Tetrahydro- Abdominal Obesity-Metabolic Syndrome	Medical Life Care Planners, LLC	Early P1	C (39)
Apple Cider Vinegar Abdominal Obesity-Metabolic Syndrome	Western University	Early P1	C (36)
Indometacinum Abdominal Obesity-Metabolic Syndrome	University of Wisconsin, Madison	Early P1	C (36)
Lactate Abdominal Obesity-Metabolic Syndrome	Gary Van Guilder	Early P1	C (36)
Biopb-01 Abdominal Obesity-Metabolic Syndrome	Vedic Lifesciences Pvt. Ltd.	N/A	D (30)
Ginger Abdominal Obesity-Metabolic Syndrome	Hamdard University	N/A	D (30)
Gynostemma Abdominal Obesity-Metabolic Syndrome	First Affiliated Hospital Xi'an Jiaotong University	N/A	D (30)
Lac Vaccinum Abdominal Obesity-Metabolic Syndrome	University of Toronto	N/A	D (30)
Milk Protein (Bovine) Abdominal Obesity-Metabolic Syndrome	University Hospital, Clermont-Ferrand	N/A	D (30)
Pentanoic Acid, 5-((8-(Fluoro-18F)Undecyl)Thio)- Abdominal Obesity-Metabolic Syndrome	University of Aarhus	N/A	D (30)
Tirzepatide Abdominal Obesity-Metabolic Syndrome	JULIO GRANADOS MONTIEL	N/A	D (30)